Examining the paracrine effects of exosomes in cardiovascular disease and repair

M Gartz, JL Strande - Journal of the American Heart Association, 2018 - Am Heart Assoc
Cardiovascular disease is the leading cause of death worldwide, accounting for almost a
third of deaths. 1 Although advances in research and cardiac care have increased survival, …

Protease-activated receptor 1 inhibition by SCH79797 attenuates left ventricular remodeling and profibrotic activities of cardiac fibroblasts

…, M Petersen, J Meyer, JL Strande - Journal of …, 2013 - journals.sagepub.com
Purpose: Fibroblast activity promotes adverse left ventricular (LV) remodeling that underlies
the development of ischemic cardiomyopathy. Transforming growth factor-β (TGF-β) is a …

Bariatric surgery as a treatment for heart failure: review of the literature and potential mechanisms

TL Kindel, JL Strande - Surgery for Obesity and Related Diseases, 2018 - Elsevier
Heart failure due to severe obesity is a complex disease due to multiple mechanisms,
including increased body mass, inflammation, and impaired cardiac metabolism that is …

[HTML][HTML] Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery

X Guan, DL Mack, CM Moreno, JL Strande, J Mathieu… - Stem cell …, 2014 - Elsevier
The ability to extract somatic cells from a patient and reprogram them to pluripotency opens
up new possibilities for personalized medicine. Induced pluripotent stem cells (iPSCs) have …

10 Gy total body irradiation increases risk of coronary sclerosis, degeneration of heart structure and function in a rat model

…, BL Fish, J Su, ST Haworth, JL Strande… - … journal of radiation …, 2009 - Taylor & Francis
… Western blot analysis of eNOS, iNOS, PAR-1, β-actin and glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) expression was carried out as previously described (Strande et al. …

[HTML][HTML] Systemic AAV8-mediated gene therapy drives whole-body correction of myotubular myopathy in dogs

…, N Gopal, VE Kelly, BK Smith, JL Strande… - Molecular Therapy, 2017 - cell.com
X-linked myotubular myopathy (XLMTM) results from MTM1 gene mutations and myotubularin
deficiency. Most XLMTM patients develop severe muscle weakness leading to respiratory …

[HTML][HTML] A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings

…, JR Parnes, N Honarpour, J Neutel, JL Strande - Nature …, 2024 - nature.com
Obesity is a major public health crisis. Multi-specific peptides have emerged as promising
therapeutic strategies for clinical weight loss. Glucagon-like peptide-1 (GLP-1) and glucose-…

SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts

JL Strande, A Hsu, J Su, X Fu, GJ Gross… - Basic research in …, 2007 - Springer
Myocardial ischemia/reperfusion (I/R) injury is partly mediated by thrombin. In support, the
functional inhibition of thrombin has been shown to decrease infarct size after I/R. Several …

Neurogenesis is absent in the brains of adult honey bees and does not explain behavioral neuroplasticity

SE Fahrbach, JL Strande, GE Robinson - Neuroscience letters, 1995 - Elsevier
The mushroom bodies, the insect brain structures most often associated with learning,
exhibit structural plasticity during adult behavioral development in honey bees. We have …

Nicorandil, a nitric oxide donor and ATP-sensitive potassium channel opener, protects against dystrophin-deficient cardiomyopathy

…, MK Childers, AD Ebert, JL Strande - Journal of …, 2016 - journals.sagepub.com
Background: Dystrophin-deficient cardiomyopathy is a growing clinical problem without
targeted treatments. We investigated whether nicorandil promotes cardioprotection in human …